EP 906 2 Pill - white round, 8mm
Pill with imprint EP 906 2 is White, Round and has been identified as Lorazepam 2 mg. It is supplied by Major Pharmaceuticals Inc.
Lorazepam is used in the treatment of Anxiety; ICU Agitation; Insomnia; Epilepsy; Light Anesthesia and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 2 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for EP 906 2
Lorazepam
- Imprint
- EP 906 2
- Strength
- 2 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Benzodiazepine anticonvulsants, Benzodiazepines, Miscellaneous antiemetics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Major Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
polacrilin potassium,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00904-6009 | Major Pharmaceuticals |
| 64125-0906 | Excellium Pharmaceutical Inc. |
More about lorazepam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,050)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: benzodiazepine anticonvulsants
- Breastfeeding
Patient resources
- Lorazepam drug information
- Lorazepam injection
- Lorazepam (Injection) (Advanced Reading)
- Lorazepam (Oral) (Advanced Reading)
- Lorazepam Tablets
Other brands
Ativan, Lorazepam Intensol, Loreev XR
Professional resources
- Lorazepam monograph
- Lorazepam (FDA)
- Lorazepam Concentrate (FDA)
- Lorazepam Injection (FDA)
- Lorazepam Oral Concentrate (FDA)
Other brands
Ativan, Lorazepam Intensol, Ativan Injection, Loreev XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
